Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis

INTRODUCTION: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antidiabetic drugs. Emerging findings from laboratory studies indicate that SGLT2 inhibitors can improve liver function and suppress the proliferation of hepatocellular carcinoma (HCC) cells. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendryx, Michael, Dong, Yi, Ndeke, Jonas M., Luo, Juhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467321/
https://www.ncbi.nlm.nih.gov/pubmed/36094949
http://dx.doi.org/10.1371/journal.pone.0274519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467321/
https://www.ncbi.nlm.nih.gov/pubmed/36094949
http://dx.doi.org/10.1371/journal.pone.0274519

Ejemplares similares